N4 Pharma (LON:N4P) Stock Price Up 25.7% – Here’s Why

N4 Pharma Plc (LON:N4P)’s stock price rose 25.7% during trading on Wednesday . The company traded as high as GBX 0.75 ($0.01) and last traded at GBX 0.66 ($0.01). Approximately 9,900,133 shares traded hands during trading, an increase of 327% from the average daily volume of 2,320,520 shares. The stock had previously closed at GBX 0.53 ($0.01).

N4 Pharma Trading Up 23.8 %

The company has a debt-to-equity ratio of 1.62, a quick ratio of 7.28 and a current ratio of 22.73. The firm has a market capitalization of £2.57 million, a P/E ratio of -55.00 and a beta of -0.37. The firm has a 50 day moving average price of GBX 0.62 and a two-hundred day moving average price of GBX 0.57.

N4 Pharma Company Profile

N4 Pharma is a specialist pharmaceutical company developing novel delivery systems for oncology, gene therapy and vaccines It has a unique silica nanoparticle delivery system called Nuvec® and another unique peptide.lipid system called Liptide® which it operates through its subsidiary Nanogenics Ltd

N4 Pharma’s business model is to partner with companies developing novel antigens in these fields to use Nuvec® as the delivery vehicle for these antigens.